Basel, North West Switzerland
Web: Novartis external link
Ort: Basel
Verwandt mit:

Research & Development at Novartis The Novartis Pharmaceuticals clinical pipeline holds a broad stream of 140 future projects including both new molecular entities and additional indications or formulations for marketed products. Our pipeline has consistently being ranked by experts as one of the strongest in the industry. Our scientists focus on diseases for which medical need remains unmet and strive to improve the drug discovery process with an approach that integrates novel concepts and tools across multiple disease areas.

Medizin 15.11
Objective is to provide patients with rapid cancer diagnostics and appropriate care - First focus will be on Ethiopia, Uganda and Tanzania - Cancer is on the rise in Africa, with more than 500,000 deaths - Novartis, the American Society for Clinical Pathology (ASCP) and the American Cancer Society (ACS) announced today they will work together to devise a common approach to improve access to  cancer treatment in Sub-Saharan Africa.
Medizin 14.11

Sandoz strengthens position as global leader in biosimilars with new immunology data from four clinical studies for proposed biosimilars adalimumab and rituximab Efficacy and safety of biosimilar a

Medizin 13.11

Subgroup of patients had a 25% reduction in major adverse cardiovascular events when treated with canakinumab in a new analysis of Phase III CANTOS trial presented at the American Heart Association

Medizin 12.11

Entresto reversed trend of worsening New York Heart Association (NYHA) class - a key measure of the severity of a patient's heart failure symptoms - improving common physical activity such as exerc

Medizin 14.11

Presentation of results from the Kisqali (ribociclib) MONALEESA-7 Phase III trial exclusively studying premenopausal women with HR+/HER2- advanced breast cancer  New MONALEESA-2 analyses focused on

Medizin 13.11

RTH258 demonstrates superiority versus aflibercept in key secondary endpoint measures of disease activity and meets primary endpoint of non-inferiority in patients with nAMD -   AMG 334 has a robu

Medizin 11.11

Poor patients in Punjab will have access to high-quality  medicines against noncommunicable, chronic diseases thanks to agreement between government and Novartis Access Punjab government will make

Jobs on